BMS CA209-370 (CHECKMATE 370) - A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to determine whether nivolumab monotherapy or in combination with Standard of care (SOC) therapies will provide clinical benefit (i.e., PFS, OS, and DOR) without unacceptable toxicity in advanced Non-Small Cell Lung Cancer patients.

See detailed information including eligibility.

11/2015
04/2022
NCT02574078
Cancer